Shp2 SUMOylation Promotes ERK Activation and Hepatocellular Carcinoma Development
Oncotarget - United States
doi 10.18632/oncotarget.3323
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 19, 2015
Authors
Publisher
Impact Journals, LLC